NORTH HAVEN, Conn., Apr 19, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of the Innovation: Delivered tour, a mobile program that will introduce surgeons, residents, nurses and hospital administrators around the country to the SILS(TM) Port Multiple Instrument Access Device.
The SILS Port is an advanced, single-incision laparoscopic device that reduces the four, Â½-inch or smaller incisions normally associated with traditional laparoscopic surgery to just one incision in the belly button. The SILS Port procedures are used in gynecologic, bariatric and urologic surgeries, among other specialties1, 2, 3, 4.
The Innovation: Delivered tour features a state-of-the-art operating room-style facility housed in an 85-foot, nearly 80,000-pound tractor-trailer that will travel around the country to bring these advanced laparoscopic surgery tools directly to surgeons and hospitals. When parked, the truck expands to a 1,200-square-foot facility with a conference room, clinical training area with advanced audio-visual tools and five operating room stations that will accommodate 10 surgeons simultaneously.
"The demand for single-incision laparoscopic surgery, an exciting and innovative technique, is increasing rapidly," said Kevin Stepp, M.D., Director of Gynecologic Surgical Education, MetroHealth/Cleveland Clinic Obstetrics and Gynecology residency program. "Medically and economically favorable, SILS procedures benefit patients and healthcare providers. I'm happy to see that the mobile facility will provide more surgeons with the opportunity to obtain the necessary training at their local hospitals in a unique and cost-effective way."
The hands-on workshops will be staffed by trained experts demonstrating the SILS Port technology and procedures. The mobile facility is fully equipped with the latest technology and resources, enabling surgeons to explore the new surgical advancements on tissue and torso trainers and to provide better patient outcomes, including less pain and improved cosmesis following surgery.
"Through innovation, collaboration and dedication, Covidien continues to lead the industry in minimally invasive surgery," said Scott Flora, President, Surgical Devices, Covidien. "We understand the demands of surgeons' schedules and the need for easy access to the latest instruments and procedures. The Innovation: Delivered tour brings these crucial tools and opportunities directly to surgeons."
The Innovation: Delivered tour is scheduled to visit 19 cities over the next few months, including: Atlanta and Macon, GA; Fayetteville, Greensboro and Raleigh, NC; Memphis, TN; and Miami and Tampa, FL.
Covidien launched the SILS Port at the 2009 annual convention of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2009 revenue of $10.7 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
1 Raman, J. et al. Single-Incision, Umbilical Laparoscopic versus Conventional Laparoscopic Nephrectomy: A Comparison of Perioperative Outcomes and Short-Term Measures of Convalescence. European Association of Urology, August 2008.
2 Saber, A. et al. Single Incision LaparoscopicSleeve Gastrectomy (SILS): A Novel Technique. Obesity Surgery, 2008.
3 Raman, J. et al. Single-Incision LaparoscopicSurgery: Initial Urological Experience and Comparison with Natural-orifice Transluminal Endoscopic Surgery. BJU International, 2008.
4 Kaouk, J. et al. Single-port Laparoscopic Surgery in Urology: Initial Experience. Urology. 2008.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6253549&lang=en